HITM-SIR: phase Ib trial of intraarterial chimeric antigen receptor T-cell therapy and selective internal radiation therapy for CEA+ liver metastases

Effective chimeric antigen receptor-modified T-cell (CAR-T) therapy for liver metastases (LM) will require innovative solutions to ensure efficient delivery and minimization of systemic toxicity. We previously demonstrated the safety of CAR-T hepatic artery infusions (HAI). We subsequently conducted...

Full description

Saved in:
Bibliographic Details
Published in:Cancer gene therapy 2020-05, Vol.27 (5), p.341-355
Main Authors: Katz, Steven C., Hardaway, John, Prince, Ethan, Guha, Prajna, Cunetta, Marissa, Moody, Ashley, Wang, Li Juan, Armenio, Vincent, Espat, N. Joseph, Junghans, Richard P.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!